TGFB1 and ovarian carcinoma: Melatonin can also attenuate angiogenesis by reducing TGFβ1, a transforming growth factor-beta1, hypoxia-inducible factor (HIF)-1α, VEGF and its receptor VEGFR2, which was demonstrated in an ovarian cancer DMBA-induced rat model9.